Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146


Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S.

Neuropharmacology. 2017 Feb;113(Pt A):281-292. doi: 10.1016/j.neuropharm.2016.10.011. Epub 2016 Oct 12.


PDYN, a gene implicated in brain/mental disorders, is targeted by REST in the adult human brain.

Henriksson R, Bäckman CM, Harvey BK, Kadyrova H, Bazov I, Shippenberg TS, Bakalkin G.

Biochim Biophys Acta. 2014 Nov;1839(11):1226-32. doi: 10.1016/j.bbagrm.2014.09.001. Epub 2014 Sep 8.


Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS.

Neuropharmacology. 2014 Nov;86:228-40. doi: 10.1016/j.neuropharm.2014.07.016. Epub 2014 Aug 10.


Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.

Chefer VI, Bäckman CM, Gigante ED, Shippenberg TS.

Neuropsychopharmacology. 2013 Dec;38(13):2623-31. doi: 10.1038/npp.2013.171. Epub 2013 Jul 18.


Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.

Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS.

Neuropsychopharmacology. 2013 Aug;38(9):1770-9. doi: 10.1038/npp.2013.76. Epub 2013 Mar 29.


Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.

Mousa SA, Shaqura M, Khalefa BI, Zöllner C, Schaad L, Schneider J, Shippenberg TS, Richter JF, Hellweg R, Shakibaei M, Schäfer M.

Diabetes. 2013 Apr;62(4):1308-19. doi: 10.2337/db12-0590. Epub 2012 Dec 10.


Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla.

Zapata A, Pontis S, Schepers RJ, Wang R, Oh E, Stein A, Bäckman CM, Worley P, Enguita M, Abad MA, Trullas R, Shippenberg TS.

J Neurosci. 2012 Sep 5;32(36):12431-6. doi: 10.1523/JNEUROSCI.2730-12.2012.


Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors.

Bagley EE, Hacker J, Chefer VI, Mallet C, McNally GP, Chieng BC, Perroud J, Shippenberg TS, Christie MJ.

Nat Neurosci. 2011 Oct 30;14(12):1548-54. doi: 10.1038/nn.2940.


The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Tejeda HA, Shippenberg TS, Henriksson R.

Cell Mol Life Sci. 2012 Mar;69(6):857-96. doi: 10.1007/s00018-011-0844-x. Epub 2011 Oct 16. Review.


Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.

Annamalai B, Mannangatti P, Arapulisamy O, Shippenberg TS, Jayanthi LD, Ramamoorthy S.

Mol Pharmacol. 2012 Jan;81(1):73-85. doi: 10.1124/mol.111.073171. Epub 2011 Oct 12.


Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration.

Chefer VI, Wang R, Shippenberg TS.

Neuropsychopharmacology. 2011 Sep;36(10):2018-29. doi: 10.1038/npp.2011.89. Epub 2011 Jun 1.


Methylene blue inhibits function of the 5-HT transporter.

Oz M, Isaev D, Lorke DE, Hasan M, Petroianu G, Shippenberg TS.

Br J Pharmacol. 2012 May;166(1):168-76. doi: 10.1111/j.1476-5381.2011.01462.x.


Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.

Mannangatti P, Arapulisamy O, Shippenberg TS, Ramamoorthy S, Jayanthi LD.

J Biol Chem. 2011 Jun 10;286(23):20239-50. doi: 10.1074/jbc.M111.226811. Epub 2011 Apr 15.


Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.

Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Bäckman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR.

FASEB J. 2011 Apr;25(4):1333-44. doi: 10.1096/fj.10-173625. Epub 2011 Jan 13.


Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats.

Zapata A, Minney VL, Shippenberg TS.

J Neurosci. 2010 Nov 17;30(46):15457-63. doi: 10.1523/JNEUROSCI.4072-10.2010.


Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Wang J, Carnicella S, Ahmadiantehrani S, He DY, Barak S, Kharazia V, Ben Hamida S, Zapata A, Shippenberg TS, Ron D.

J Neurosci. 2010 Oct 27;30(43):14502-12. doi: 10.1523/JNEUROSCI.3909-10.2010.


Regulation of monoamine transporters: Role of transporter phosphorylation.

Ramamoorthy S, Shippenberg TS, Jayanthi LD.

Pharmacol Ther. 2011 Feb;129(2):220-38. doi: 10.1016/j.pharmthera.2010.09.009. Epub 2010 Oct 15. Review.


Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain.

Kaminski RM, Núñez-Taltavull JF, Budziszewska B, Lasoń W, Gasior M, Zapata A, Shippenberg TS, Witkin JM.

Neurochem Res. 2011 Jan;36(1):146-52. doi: 10.1007/s11064-010-0284-2. Epub 2010 Oct 7.


Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+.

Oz M, Libby T, Kivell B, Jaligam V, Ramamoorthy S, Shippenberg TS.

J Neurochem. 2010 Aug;114(4):1019-29. doi: 10.1111/j.1471-4159.2010.06828.x. Epub 2010 May 26.


The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Tejeda HA, Chefer VI, Zapata A, Shippenberg TS.

Psychopharmacology (Berl). 2010 Jun;210(2):231-40. doi: 10.1007/s00213-010-1799-6. Epub 2010 Mar 16.


The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.

Yang KH, Galadari S, Isaev D, Petroianu G, Shippenberg TS, Oz M.

J Pharmacol Exp Ther. 2010 May;333(2):547-54. doi: 10.1124/jpet.109.162594. Epub 2010 Feb 16.


The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.

Oz M, Jaligam V, Galadari S, Petroianu G, Shuba YM, Shippenberg TS.

J Neurochem. 2010 Mar;112(6):1454-64. doi: 10.1111/j.1471-4159.2009.06557.x. Epub 2009 Dec 24.


Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Chefer VI, Denoroy L, Zapata A, Shippenberg TS.

Eur J Neurosci. 2009 Jul;30(2):272-8. doi: 10.1111/j.1460-9568.2009.06827.x. Epub 2009 Jul 15.


Detection and quantification of neurotransmitters in dialysates.

Zapata A, Chefer VI, Shippenberg TS, Denoroy L.

Curr Protoc Neurosci. 2009 Jul;Chapter 7:Unit 7.4.1-30. doi: 10.1002/0471142301.ns0704s48.


Microdialysis in rodents.

Zapata A, Chefer VI, Shippenberg TS.

Curr Protoc Neurosci. 2009 Apr;Chapter 7:Unit7.2. doi: 10.1002/0471142301.ns0702s47.


Overview of brain microdialysis.

Chefer VI, Thompson AC, Zapata A, Shippenberg TS.

Curr Protoc Neurosci. 2009 Apr;Chapter 7:Unit7.1. doi: 10.1002/0471142301.ns0701s47.


Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.

Cassano T, Gaetani S, Morgese MG, Macheda T, Laconca L, Dipasquale P, Taltavull J, Shippenberg TS, Cuomo V, Gobbi G.

Neurochem Res. 2009 Aug;34(8):1417-26. doi: 10.1007/s11064-009-9928-5. Epub 2009 Feb 20.


Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Shippenberg TS, LeFevour A, Chefer VI.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):442-53. Review.


The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?

Shippenberg TS.

Neuropsychopharmacology. 2009 Jan;34(1):247. doi: 10.1038/npp.2008.165. Review. No abstract available.


Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.

Shippenberg TS, Chefer VI, Thompson AC.

Biol Psychiatry. 2009 Jan 15;65(2):169-74. doi: 10.1016/j.biopsych.2008.09.009. Epub 2008 Oct 31.


Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.

Chefer VI, Shippenberg TS.

Neuropsychopharmacology. 2009 Mar;34(4):887-98. doi: 10.1038/npp.2008.128. Epub 2008 Aug 13.


Microdialysis in rodents.

Thompson AC, Shippenberg TS.

Curr Protoc Neurosci. 2001 May;Chapter 7:Unit7.2. doi: 10.1002/0471142301.ns0702s00.


Overview of microdialysis.

Shippenberg TS, Thompson AC.

Curr Protoc Neurosci. 2001 May;Chapter 7:Unit7.1. doi: 10.1002/0471142301.ns0701s00.


Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation.

Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS.

Pain. 2008 Aug 31;138(2):423-39. doi: 10.1016/j.pain.2008.01.023. Epub 2008 Mar 19.


Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.

Gehrke BJ, Chefer VI, Shippenberg TS.

Psychopharmacology (Berl). 2008 Apr;197(3):509-17. doi: 10.1007/s00213-007-1067-6. Epub 2008 Feb 2.


The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla.

Schepers RJ, Mahoney JL, Zapata A, Chefer V, Shippenberg TS.

J Neurochem. 2008 Feb;104(3):806-17. Epub 2007 Oct 24.


Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.

Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS.

J Biol Chem. 2007 Dec 7;282(49):35842-54. Epub 2007 Oct 8.


Dynorphin and the pathophysiology of drug addiction.

Shippenberg TS, Zapata A, Chefer VI.

Pharmacol Ther. 2007 Nov;116(2):306-21. Epub 2007 Jul 24. Review.


Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception.

Schepers RJ, Mahoney JL, Shippenberg TS.

Pain. 2008 Jun;136(3):320-30. Epub 2007 Aug 30.


The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

Oz M, Yang KH, Dinc M, Shippenberg TS.

J Pharmacol Exp Ther. 2007 Nov;323(2):547-54. Epub 2007 Aug 6.


D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.

Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS.

Mol Pharmacol. 2007 May;71(5):1222-32. Epub 2007 Jan 31.


The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons.

Riegel AC, Zapata A, Shippenberg TS, French ED.

Neuropsychopharmacology. 2007 Jul;32(7):1558-69. Epub 2007 Jan 10.


Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling.

Kaminski RM, Witkin JM, Shippenberg TS.

Neuropharmacology. 2007 Mar;52(3):895-903. Epub 2006 Nov 28.


Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.

Doyon WM, Howard EC, Shippenberg TS, Gonzales RA.

Neuropharmacology. 2006 Sep;51(3):487-96. Epub 2006 Jun 15.


Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex.

Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2938-42. Epub 2006 Feb 13.


Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens.

Chefer VI, Zapata A, Shippenberg TS, Bungay PM.

J Neurosci Methods. 2006 Sep 15;155(2):187-93. Epub 2006 Feb 8.


Supplemental Content

Loading ...
Support Center